539561 — Remedium Lifecare Share Price
0.000.00%
Last trade - 00:00- IN₹733.82m
- IN₹2.50bn
- IN₹40.42bn
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 1.57 | ||
| Price to Tang. Book | 1.57 | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 0.05 | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | -71.49% | ||
| Return on Equity | -61.59% | ||
| Operating Margin | -2.12% | ||
Financial Summary
| Year End 31st Mar | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | IN₹m | n/a | 900.34 | 5,047.92 | 5,098.37 | 40,417.07 | n/a | n/a | 255.4% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | +124.28 | +403.38 | +503.23 | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Remedium Lifecare Limited is a pharmaceutical company, which is aligned across two business verticals, such as Products and Services. Products business comprises the trading and sale of active pharmaceutical ingredients (APIs) and intermediates to innovators and generic pharmaceutical players in both domestic and international markets, including the regulated markets. It is engaged in the business of trading in Advanced Pharmaceutical Intermediates, API’s and other pharma products used, including Iso propyl Alcohol (IPA), Cyclohexane, DI Iso Propyl Amine, Ethyl Acetate, Hydrazine Hydrate, IPA, Methylene Di Chloride, Potassium Carbonate Powder, Sodium Bi-Carbonate, Potassium Hydroxide Flakes, Sodium Chloride (Common Salt), Sodium Carbonate (SODA ASH), Amino isophthalic Acid, Tellurium(IV) Oxide, Grignard Reagent, Iodine, Selenium Metal Powder, Trimethyl Sulfoxonium Iodide. It also manufactures various APIs, such as Atorvastatin Calcium (Amorphous), Citalopram Hydrochloride and others.
Directors
- Last Annual
- March 31st, 2024
- Last Interim
- December 31st, 2024
- Incorporated
- February 19th, 1988
- Public Since
- January 12th, 2016
- No. of Shareholders
- 15,587
- No. of Employees
- 7
- Sector
- Pharmaceuticals
- Industry
- Healthcare
- Exchange
- Bombay Stock Exchange
- Shares in Issue
- 403,200,000
- Address
- 116-C Focal Point, MUMBAI, 400059
- Web
- https://www.remlife.com/
- Phone
- +91 2228505005
- Auditors
- M/s Taori Sandeep & Associates
Upcoming Events for 539561
Remedium Lifecare Ltd Annual Shareholders Meeting
Q1 2026 Remedium Lifecare Ltd Earnings Release
Similar to 539561
Aayush Wellness
Bombay Stock Exchange
Achyut Healthcare
Bombay Stock Exchange
Adline Chem Lab
Bombay Stock Exchange
MPS Pharmaa
Bombay Stock Exchange
Albert David
Bombay Stock Exchange
FAQ
What is the Remedium Lifecare share price?
As of Today at 22:55 UTC, shares in Remedium Lifecare are trading at IN₹1.79. This share price information is delayed by 15 minutes.
How has the Remedium Lifecare share price performed this year?
Shares in Remedium Lifecare last closed at IN₹1.79 and the price had moved by -90.5% over the past 365 days. In terms of relative price strength the Remedium Lifecare share price has underperformed the S&P BSE 100 Index by -91.05% over the past year.
What are the analyst and broker recommendations for Remedium Lifecare?
There is no consensus recommendation for this security.
Find out moreWhat is the Remedium Lifecare dividend yield?
Remedium Lifecare does not currently pay a dividend.
Does Remedium Lifecare pay a dividend?
Remedium Lifecare does not currently pay a dividend.
When does Remedium Lifecare next pay dividends?
Remedium Lifecare does not currently pay a dividend.
How do I buy Remedium Lifecare shares?
To buy shares in Remedium Lifecare you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of Remedium Lifecare?
As of the previous close price of IN₹1.79, shares in Remedium Lifecare had a market capitalisation of IN₹733.82m.
Where are Remedium Lifecare shares listed?
Here are the trading details for Remedium Lifecare:
- Country of listing: India
- Exchange: BSE
- Ticker Symbol: 539561
What kind of share is Remedium Lifecare?
Based on an overall assessment of its quality, value and momentum Remedium Lifecare is currently classified as a Value Trap. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a Remedium Lifecare share price forecast for 2025?
We could not find analyst target price data for this security.
Find out moreWhat is the trend in the Remedium Lifecare share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Remedium Lifecare. Over the past six months, its share price has underperformed the S&P BSE 100 Index by -55.84%.
As of the last closing price of IN₹1.79, shares in Remedium Lifecare were trading -63.25% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the Remedium Lifecare PE Ratio?
The Remedium Lifecare PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at IN₹1.79.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of Remedium Lifecare?
We do not have data on Remedium Lifecare's directors